Recent GlaxoSmithKline News
Investing Articles
This fast-growing pharmaceutical stock blows GlaxoSmithKline plc out of the water
Investing Articles
2 top Neil Woodford stocks for your ISA
Investing Articles
2 Neil Woodford stocks set to beat the FTSE 100
Investing Articles
Why I’ll likely hold GlaxoSmithKline plc and Diageo plc forever
Investing Articles
Missed the ISA deadline? Start investing for next year today
Investing Articles
2 FTSE 100 growth stars with dividend yields above 4%
Investing Articles
2 FTSE 100 stocks I’d buy with 4%+ dividend yields
Investing Articles
2 Footsie growth and income shares for your ISA
Investing Articles
2 safe FTSE 100 shares with dividend yields above 4%
Investing Articles
Is a GlaxoSmithKline plc buyout back on the cards?
Investing Articles
Why I’d buy and hold Hikma Pharmaceuticals plc for the next decade
Investing Articles
2 shares with explosive growth potential
Investing Articles
2 FTSE 100 stocks I’d happily buy and never sell
Investing Articles
3 Neil Woodford stocks I’d buy in March
Investing Articles
Should you buy the FTSE 100 stocks Warren Buffett sold?
Investing Articles
Retire early on these 3 stocks
Investing Articles
3 big yielders I’d buy and hold for the next 5 years
Investing Articles
2 dependable shares to retire on
Investing Articles
3 mega cheap FTSE 100 dividend stocks
Investing Articles
3 hot dividend stocks I’d buy in March
Investing Articles
Don’t take 1.15% from Premium Bonds when these 2 income stocks pay over 5%
Investing Articles
Is this the most undervalued stock on the FTSE 100 today?
Investing Articles
Are shares in GlaxoSmithKline plc now in bargain territory?
Investing Articles
2 FTSE 100 stocks I’d buy in February and 1 I’d sell
Investing Articles
These 3 income stocks could make you long-term rich
Investing Articles
Top stocks for troubled times
Investing Articles
3 Footsie giants you should consider buying before it’s too late
Investing Articles
Why I see 50% upside in this pharmaceutical firm in 2017
Investing Articles
Does this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc?